research funding database


Opsoclonus-Myoclonus Syndrome (OMS) (pediatric neurology | worldwide)

Share this post

ERC webinar 2024
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Opsoclonus-Myoclonus Syndrome (OMS)  from The Pablove Foundation supports pediatric neurology researchers working on the rare disease Opsoclonus-Myoclonus Syndrome (OMS). Applicants may be based anywhere in the world. Applicants must hold an MD or PhD. The Grant provides funding of 100,000 USD over 2 years. Upon timely submission of the required deliverables, an additional 5% of the award amount (up to $2,500) will be provided to the sponsoring institutions to cover indirect costs (F&A) at the end of the grant’s performance period.

Applications open on May 15, 2024. Letters of intent are due on July 1, 2024. Invited full applications are due on October 8, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
monthly funding newsletter

unsubscribe at any time